IGFBP4 and cancer: Others, including PKP3(Furukawa et al., 2005), TJP3 (Luo et al., 2020), NRIP1 (Chen X. et al., 2020), DNAJC12 (Uno et al., 2019), ASS1(Silberman et al., 2019), BATF (Feng et al., 2020), NMU (Liu et al., 2019), and IGFBP4 (Lee et al., 2018), had been verified to participate in carcinogenesis and affect patients’ prognoses in other cancers, although the relevant studies were rare in UCEC.